Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for Harvard Bioscience (HBIO) over the last 16 years, with Q3 2025 value amounting to $3.3 million.

  • Harvard Bioscience's Prepaid Assets fell 370.48% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year decrease of 370.48%. This contributed to the annual value of $2.9 million for FY2024, which is 2644.67% down from last year.
  • Harvard Bioscience's Prepaid Assets amounted to $3.3 million in Q3 2025, which was down 370.48% from $3.3 million recorded in Q2 2025.
  • In the past 5 years, Harvard Bioscience's Prepaid Assets ranged from a high of $5.8 million in Q3 2021 and a low of $2.9 million during Q4 2024
  • For the 5-year period, Harvard Bioscience's Prepaid Assets averaged around $4.3 million, with its median value being $4.3 million (2021).
  • As far as peak fluctuations go, Harvard Bioscience's Prepaid Assets soared by 4572.86% in 2021, and later crashed by 3118.26% in 2025.
  • Quarter analysis of 5 years shows Harvard Bioscience's Prepaid Assets stood at $4.3 million in 2021, then fell by 20.02% to $3.5 million in 2022, then increased by 13.48% to $3.9 million in 2023, then dropped by 26.45% to $2.9 million in 2024, then rose by 13.01% to $3.3 million in 2025.
  • Its last three reported values are $3.3 million in Q3 2025, $3.3 million for Q2 2025, and $3.1 million during Q1 2025.